{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Atara Biotherapeutics, Inc."},"Symbol":{"label":"Symbol","value":"ATRA"},"Address":{"label":"Address","value":"611 GATEWAY BOULEVARD,SUITE 900 SUITE 200, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 278-8930"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs."},"CompanyUrl":{"label":"Company Url","value":"https://www.atarabio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anhco Nguyen","title":"President, Chief Executive Officer & Director"},{"name":"Rajani Dinavahi","title":"Chief Medical Officer & Senior Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}